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Purpose: The aim of this study was to investigate hyaluronic acid (HA) protection on cultured human corneal epithelial
cells (HCEs) against benzalkonium chloride (BAC)-induced DNA damage and intracellular reactive oxygen species (ROS)
increase.
Methods: Cells were incubated with different concentrations of BAC with or without the presence of 0.2% HA for 30
min. DNA damage to HCEs was examined by alkaline comet assay and by immunofluorescence microscopic detection
of the phosphorylated form of histone variant H2AX (γH2AX) foci. ROS production was assessed by the fluorescent
probe, 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA). Cell apoptosis was determined with annexin V staining by
flow cytometry.
Results: HA significantly reduced BAC-induced DNA damage as indicated by the tail length (TL) and tail moment (TM)
of alkaline comet assay and by γH2AX foci formation, respectively. Moreover, HA significantly decreased BAC-induced
ROS increase and cell apoptosis. However, exposure to HA alone did not produce any significant change in DNA damage,
ROS generation, or cell apoptosis.
Conclusions: BAC could induce DNA damage and cell apoptosis in HCEs, probably through increasing oxidative stress.
Furthermore, HA was an effective protective agent that had antioxidant properties and could decrease DNA damage and
cell apoptosis induced by BAC.
Hyaluronic acid (HA) exists as a high molecular weight
biologic polymer of the extracellular matrix, composed of
repeating disaccharide units of (β,1–4)-D-glucuronic acid-(β,
1–3)-N-acetyl-D-glucosamine [1]. In the eye, HA is abundant
in the vitreous body and in low concentrations in the aqueous
humor [2]. Among extracellular matrix molecules, HA has
unique hygroscopic, rheological, and viscoelastic properties
[3]. HA has been used as a tear substitute for dry eyes to
increase tear film stability and reduce subjective symptoms,
such as ocular irritation and burning [4-6]. It has also been
used in ophthalmic practice to protect the corneal endothelium
and maintain the anterior chamber depth during intraocular
surgery [7,8]. Furthermore, in vitro models have demonstrated
that HA might play an important role in corneal epithelial
development, wound healing and inflammation [9-13].
Preservatives such as benzalkonium chloride (BAC) are
used in most ophthalmic preparations to prevent bacterial
contamination. The mechanism of the antimicrobial action of
BAC is thought to be due to disruption of the cell membranes
Juan Ye, M.D., Ph.D., Eye Center of the 2nd Affiliated Hospital,
Medical  College  of  Zhejiang  University,  Hangzhou,  Zhejiang
310009,  China;  Phone:  +86-571-87783897;  FAX:
+86-571-87783897;  email:  yejuan@zju.edu.cn  or
yejuan_99@yahoo.com.cn
of microorganisms. Several studies have confirmed that BAC
could  enhance  drug  penetration  and  improve  topical
bioavailability  of  ophthalmic  drugs  [14-16].  Although
topically administered medications are increasingly used with
apparent safety and good tolerance, there is growing evidence
that long-term use of topical drugs containing BAC may have
adverse effects on the corneal epithelium. Many in vivo and
in vitro studies have been developed to predict the toxic effects
of BAC on corneal and conjunctival epithelium, such as ocular
irritation, corneal surface impairment, tear film instability,
corneal epithelial barrier dysfunction, cell apoptosis, and the
potential risk of failure for future glaucoma surgery [17-21].
In our previous study, we showed that exposure to BAC
in  human  corneal  epithelial  cells  (HCEs)  even  at  low
concentrations could induce DNA strand breaks, which were
still present after BAC removal [22]. In the current study, we
examined whether HA could influence the effects of BAC on
HCEs. As reported herein, we found that HA could protect
HCEs  from  the  BAC-induced  genotoxic  effects  and  ROS
formation.
METHODS
Cell  culture:  Simian  virus  (SV)  40-immortalized  human
corneal epithelial cells (HCEs) [23] were provided by New
York  University  (New  York,  NY)  and  were  cultured  in
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3364DMEM/F12 (Gibco, Grand Island, NY), supplemented with
10% fetal bovine serum (Gibco), 5 µg/ml insulin (Gibco),
0.1 µg/ml cholera toxin, 5 ng/ml human epidermal growth
factor (Gibco), and 40 µg/ml gentamicin and cultured in 25
cm2 cell culture flasks at 37 °C in an atmosphere of 95% air
and 5% CO2. Confluent cultures were removed by 0.25%
trypsin-EDTA (Sigma Aldrich, St. Louis, MO) incubation,
and cells were counted, plated on sterile glass coverslips for
the phosphorylated form of histone variant H2AX (γH2AX)
detection, in six-well plates for alkaline comet assay, reactive
oxygen species (ROS), and apoptosis detection.
Cell  treatments:  When  cells  reached  approximately  80%
confluence, the culture medium was removed. Cells were
incubated for 30 min with 0.00005%, 0.0001%, 0.0005%, and
0.001% BAC (BAC/HA-), or treated with a combination of
0.2% HA (1,000 kDa; Freda Biopharm Co., Ltd., Shandong,
China)  and  different  concentrations  of  BAC  (BAC/HA+).
BAC and HA were dissolved in culture medium; thus culture
medium was used as a negative control.
DNA  damage  detection:  DNA  damage  was  examined  by
comet  assay  and  by  immunofluorescence  microscope
detection of γH2AX foci.
Comet assay—The alkaline comet assay was performed
as previously described with some modiﬁcations [24]. First,
the fully frosted microscope slide was covered with 100 μl of
0.65% normal melting point (NMP) agarose and immediately
covered with a coverslip. Slides were placed on ice to allow
the agarose to solidify. Second, cells were mixed with 0.65%
low melting point (LMP) agarose (75 μl) to form an LMP-cell
suspension. After putting the coverslip back, the slide was
allowed to solidify on ice for several min. Third, another layer
of  agarose  (75  μl  of  0.65%  LMP  agarose)  was  added  as
described before. Following slide preparation, the embedded
cells were lysed by gently immersing the slides in the freshly
prepared ice-cold lysis solution (2.5 M NaCl, 100 mM EDTA,
10 mM Tris, with 1% Triton X-100 and 10% DMSO added
just before use, pH 10). After at least 1 h at 4 °C in the dark,
the lysis solution was removed, and the slides were rinsed
three times with distilled water. The slides were then placed
in a horizontal gel electrophoresis chamber filled with fresh
buffer (300 mM NaOH, 1 mM EDTA, pH>13) for 20 min to
allow DNA to unwind. Electrophoresis was conducted in the
same buffer at 20 V and 300 mA for 20 min. Then the slides
were washed twice in a neutralization buffer (0.4 M Tris,
pH7.5) and fixed in methanol for 3 min. The slides were
stained with 20 μg/ml ethidium bromide and observed using
an Olympus AX70 fluorescent microscope (Olympus, Tokyo,
Japan).  The  tail  length  (TL)  and  tail  moment  (TM)  was
measure  by  ImagePro  Plus  software  (Media  Cybernetics,
Silver Spring, MD) in at least 100 cells on one slide.
Immunofluorescent microscopy and quantification of
γH2AX  foci—Immunofluorescent  microscopy  was
performed  basically  the  same  as  described  earlier  with
modifications [25]. In short, after treatment, cells were fixed
in 4% paraformaldehyde for 15 min, washed twice with PBS,
and permeabilized in 0.2% Triton X-100 (Sigma). After being
blocked with 3% blocking serum albumin (Sigma) for 1.5 h,
samples were incubated with 1:1,000 mouse monoclonal anti-
γH2AX antibody (Upstate Technology, Lake Placid, NY) for
2  h,  followed  by  1:500  FITC-conjugated  goat-anti-mouse
secondary antibody (AF488; Invitrogen, Carlsbad, CA) for 1
h. To stain the nuclei, 4',6-diamidino-2-phenylindole (DAPI)
was added to the cells and incubated for another 15 min. The
coverslip was then removed from the plate, mounted on a glass
slide,  and  observed  with  an  Olympus  AX70  fluorescent
microscope (Olympus). To prevent bias in selection of cells
that display foci, all the cells were counted in the field of vision
(at least 50 cells). Image Pro Plus (Media Cybernetics) was
used to count the γH2AX foci in each cell.
Intracellular  ROS  detection:  ROS  was  measured  with
membrane  permeable  dye  2′,7′-dichlorodihydrofluorescein
diacetate molecule probes (DCFH-DA; Sigma), using a slight
modification of the previously published method [26]. Cells
were  collected  and  centrifuged,  and  supernatant  was
discarded.  The  pellet  was  washed  twice  with  PBS,
resuspended  in  PBS  containing  a  final  concentration  of
10 μM DCFH-DA. After a 30-min incubation, the cells were
centrifuged  and  washed  three  times  with  PBS.  After
resuspension with PBS, cells were measured immediately,
using flow cytometry (Cytomics FC 500; Beckman Coulter
Inc., Miami, FL) to monitor the formation of the fluorescent-
oxidized derivative of DCFH-DA at an emission wavelength
of 525 nm and an excitation wavelength of 488 nm. ROS were
detected immediately after incubation to provide reliable data.
Statistical analysis was performed using specialized software
(CXP software; Beckman Coulter Inc.). For each sample, at
least  10,000  events  were  analyzed  in  each  of  three
independent experiments. The ROS level was represented as
the  mean  fluorescence  intensity  (MFI)  of  DCFH-DA  in
treated sample/the MFI in control group.
Flow cytometry analysis of cell apoptosis: The annexin V-
ﬂuorescein isothiocyanate (FITC)/propidium iodide (PI) kit
(Biovison.  Int.,  Mountain  View,  CA)  was  used  to  assess
modifications of the cell membrane that are associated with
program  med  cell  death.  Experiments  were  conducted
according to the manufacturer’s instructions. In short, after
treatment  with  BAC,  cells  were  collected,  counted,
centrifuged, and resuspended to 5×105 cells in 500 μl of 1×
binding buffer. Annexin V-FITC (5 μl) and 10 μl PI were
added to each sample. The samples were incubated in the dark
at room temperature for 5 min. Samples were then examined
immediately on the Cytomics FC 500 flow cytometry using
the CXP software for data analysis. At least 5,000 cells were
analyzed in each treatment group.
Statistical analysis: Each experiment was conducted at least
three  times.  Statistical  analysis  was  performed  with  the
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multiple  comparison  test  (GraphPad  Prism  5  software;
GraphPad Software, San Diego, CA). Statistically significant
differences between groups were considered to have a p value
of <0.05. Results were expressed as the mean±standard error
of more than three experiments.
RESULTS
HA significantly reduced BAC-induced DNA damage detected
by comet assay: In our previous study, we confirmed that BAC
could cause DNA single-strand breaks (SSBs) as indicated by
Olive tail moment (OTM) of alkaline comet assay [22]. In
addition, as shown in Figure 1, it was found that BAC had a
clear  dose-dependent  effect  on  DNA  fragmentation  as
indicated by the tail length (TL) and tail moment (TM) of
alkaline  comet  assay  (p<0.001  compared  to  the  control
group). Furthermore, cells treated with a combination of 0.2%
HA and BAC showed significantly fewer TM and TL than
those treated with BAC alone (Figure 1; p<0.001).
HA significantly decreased DSBs induced by BAC: γH2AX
foci, which represent phosphorylation at Ser139 of histone
variant H2AX, are used as sensitive biomarkers for DNA
double strand breaks (DSBs) [27]. We recently proved that
higher concentrations of BAC could yield more γH2AX foci
in HCEs [22]. As shown in Figure 2A, the percentages of
γH2AX foci-positive cells in four concentrations of BAC-
treated cells were significantly greater than those found in the
control cells (p<0.001). Cells treated with a combination of
0.2%  HA  and  four  concentrations  of  BAC  resulted  in  a
significantly smaller number of γH2AX foci-positive cells
compared  to  BAC-exposed  cells  without  HA  incubation
(p<0.01; Figure 2A); however, the cells incubated with a
combination  of  0.2%  HA  and  0.001%  BAC  showed  a
significant increase in the percentage of γH2AX foci-positive
cells compared to the control cells (p<0.01; Figure 2A).
HA  significantly  decreased  BAC-induced  oxidative  stress:
ROS production was represented as the mean fluorescence
intensity (MFI) of DCFH-DA in treated sample/the MFI in
control group. After incubation for 30 min, there was a dose-
dependent increase of ROS production in each BAC/HA--
treated group. The MFI of the various concentrations of BAC
increased to 163.8%, 229.5%, 345.4%, and 507.0% compared
to  control  groups,  respectively,  each  of  which  was
significantly  higher  than  those  found  in  the  control  cells
(p<0.05; Figure 3). 0.2% HA incubation inhibited the increase
in  ROS  generation  induced  by  BAC  (p<0.01;  Figure  3);
however, cells treated with a combination of 0.2% HA and
BAC  showed  a  significant  increase  in  ROS  production
compared to the control cells (p<0.05; Figure 3).
HA  significantly  decreased  BAC-induced  cell  apoptosis:
After 30 min incubation with BAC, no significant differences
in apoptosis of HCEs were found at concentrations ranging
from 0.00005% to 0.0005% (p>0.05 compared to the control,
Figure 4). At a concentration of 0.001%, the percentage of
apoptotic cells was 22.1% as compared with the control group
(4.8%), p<0.001, which represented a significant increase.
0.2% HA significantly decreased 0.001% BAC-induced cell
apoptosis  (p<0.01;  Figure  4);  however,  the  percentage  of
apoptotic cells in 0.001% BAC/HA+-treated group showed a
significant increase compared to the control cells (p<0.001;
Figure 4).
Figure 1. Alkaline comet assay showed that HA could reduce BAC-
induced  DNA  damage.  HCEs  were  treated  with  four  different
concentrations of BAC with or without 0.2% HA. A: Tail length
(TL). B: Tail moment (TM). C: Representative images of alkaline
comet assay. Incubation at various concentrations of BAC for 30 min
produced a significant increase in the level of TL and TM, whereas
a combination of 0.2% HA and BAC showed a significant decrease.
Differences were significant at p<0.001 (three asterisks) compared
to control cells, and p<0.001 (three hash marks) compared between
cells treated with BAC alone (BAC/HA-) and cells treated with a
combination of 0.2% HA and BAC (BAC/HA+).
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BAC  is  commonly  used  as  a  preservative  in  most  ocular
medications, and the most common concentration of BAC
used in eye drops ranges from 0.001% to 0.1%. In accordance
with previous in vitro studies [19,28-30], we confirmed that
BAC was a toxic agent. The objective of this study was to
investigate in vitro whether HA could protect human corneal
epithelial cells from the genotoxic effects of BAC treatment.
Figure 2. The results of γH2AX foci formation in HCEs after BAC
with or without HA treatment. A: The percentage of γH2AX foci-
positive cells. After 30 min incubation, four concentrations of BAC-
treated cells showed a significant increase DSBs compared to the
control group, whereas a combination of 0.2% HA and BAC resulted
in a significantly smaller number of DSBs. The cells treated with a
combination of 0.2% HA and 0.001% BAC showed a significant
increase in the percentage of γH2AX foci-positive cells compared to
the control cells. B: Representative images of γH2AX foci. The
nuclei stained by DAPI exhibit in blue, while the γH2AX foci stained
by FITC exhibit in green. Differences were significant at p<0.01 (two
asterisks) and p<0.001 (three asterisks) compared to control cells,
and  p<0.01  (two  hash  marks)  and  p<0.001  (three  hash  marks)
compared between cells treated with BAC alone (BAC/HA-) and
cells treated with a combination of 0.2% HA and BAC (BAC/HA+).
The alkaline comet assay is a sensitive method for direct
visualization of DNA single-strand breaks (SSBs) on the level
of a single cell [31]. γH2AX foci formation has been suggested
as another specific and sensitive indicator for DNA double-
strand breaks (DSBs) [32]. Moreover, the disappearance of
γH2AX foci is associated with the complication of DSBs
repair  [33].  The  results  of  our  alkaline  comet  assay
demonstrated that BAC had a clear dose-dependent effect on
DNA fragmentation as indicated by the tail length (TL) and
tail moment (TM) (Figure 1). BAC-induced DSBs, detected
by γH2AX immunofluorescent staining, were also observed
in HCEs in a dose-dependent manner (Figure 2). In the present
study, HA effectively reduced the SSBs and DSBs induced by
BAC in HCEs, demonstrating a genoprotective effect.
Oxidative stress has been recognized as one of the main
causes of DNA damage. It is well known that reactive oxygen
species  (ROS)  are  generated  as  a  by-product  of  normal
mitochondrial activity in aerobic cells. ROS overproduction
can  cause  severe  damage  to  cellular  macromolecules,
especially the DNA [34]. Experimental studies revealed that
in vitro many extracellular stimuli could influence the redox
cycling  pathway,  causing  the  formation  of  ROS  and
eventually leading to SSBs and DSBs [35,36]. Debbascb et al.
[37] proposed that oxidative stress might play an important
role  in  tissue  damage  induced  by  BAC  in  ocular  surface
disorders. In our study, a dose-related increase in ROS levels
Figure 3. HA significantly decreased BAC-induced oxidative stress.
ROS production significantly increased after 30 min of exposure at
four concentrations of BAC, which was inhibited by 0.2% HA.
However, cells treated with a combination of 0.2% HA and BAC
showed a significant increase in ROS production compared to the
control cells. Differences were significant at p<0.05 (one asterisk),
p<0.01 (two asterisks), and p<0.001 (three asterisks) compared to
control cells, and p<0.01 (two hash marks) and p<0.001 (three hash
marks)  compared  between  cells  treated  with  BAC  alone  (BAC/
HA-) and cells treated with a combination of 0.2% HA and BAC
(BAC/HA+).
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of BAC (Figure 3). It was possible that the surplus ROS
produced  by  BAC  disturbed  the  balance  between  the
oxidation and reduction systems, eventually leading to DNA
damage.
Preliminary in vitro studies have demonstrated that BAC
could induce arrest of cellular growth and cell death on both
corneal  and  conjunctival  epithelial  cells  [20,29].  We  also
observed a significantly increased apoptosis in HCEs after 30
min of treatment with BAC 0.001% (Figure 4). It has been
reported that DNA damage can have dramatic effects on cell
cycle arrest, apoptosis, or oncogenesis [38,39]. In addition,
Figure 4. HA significantly decreased BAC-induced cell apoptosis.
A: No significant differences in apoptosis of HCEs cells were found
at concentrations ranging from 0.00005% to 0.0005%. 0.001% BAC
showed a significant increase in cell apoptosis, whereas 0.2% HA
was significantly decreased 0.001% BAC-induced cell apoptosis.
Cell apoptosis in 0.2% HA and 0.001% BAC co-incubated group
showed a significantly increase compared to the control cells. B:
Representative  images  of  cell  apoptosis  examined  by  the  flow
cytometry. Differences were significant at p<0.001 (three asterisks)
compared to control cells, and p<0.01 (two hash marks) compared
between cells treated with BAC alone (BAC/HA-) and cells treated
with a combination of 0.2% HA and BAC (BAC/HA+).
Buttke et al. [40] confirmed that excessive levels of ROS could
induce apoptosis in various cell types. Therefore, we supposed
that  higher  concentrations  of  BAC  could  cause
overproduction of ROS, which might influence the cellular
viability by inducing more SSBs and DSBs.
HA is a remarkable biopolymer that appears to have an
impressive array of biologic functions. Human studies have
confirmed  that  HA  could  increase  tear  film  stability  and
reduce  subjective  symptoms  of  dry  eyes,  such  as  ocular
irritation and burning [4-6]. Furthermore, several experiments
in  animals  have  shown  that  HA  could  promote  corneal
epithelial  wound  healing  by  stimulating  the  migration,
adhesion, and proliferation of the corneal epithelium [9,41].
In vitro models have also demonstrated that HA could protect
cells against cell death, inflammation, and oxidative stress in
ocular surface epithelial cells [13,42]. In our present study, we
demonstrated that exposure to HA alone did not induce any
toxicity in HCEs, which was consistent with the study of
Pauloin  et  al.  [43].  We  also  observed  that  HA  possessed
antioxidant and anti-apoptotic properties. Results showed that
cell apoptosis and oxidative stress was significantly lower in
0.2% HA and BAC co-incubated cells than those treated with
BAC alone (Figure 3 and Figure 4). In addition, alkaline comet
and γH2AX foci assays showed that HA effectively reduced
the SSBs and DSBs induced by BAC in HCEs (Figure 1 and
Figure 2). These results lead to the conclusion that HA had a
significant protective effect. A possible explanation was that
HA with negative charges could neutralize the toxic effect
caused  by  the  cationic  charge  of  the  BAC  quaternary
ammoniums  to  the  corneal  epithelial  cells  [42].  Another
hypothesis  was  that  the  viscous  biopolymer  formed  a
protective coat on cell membrane by binding to specific cell-
surface receptors including CD44, which was demonstrated
to  be  expressed  in  the  corneal  epithelial  cells  [43],  thus
decreasing the interaction between the toxic agents and the
cells. Furthermore, HA is rich in hydroxyl functions that can
potentially absorb ROS [43]. Thus, we suggested that HA
indirectly prevented BAC-induced DNA strand breaks and
cell apoptosis in HCEs by decreasing ROS production.
In conclusion, our data showed that the preservative BAC
could  cause  intracellular  ROS  overproduction,  and  cause
DNA  strand  breaks  and  cell  death  in  HCEs  even  at  low
concentrations. In addition, HA, which had no toxic effect on
HCEs, could significantly reduce all the BAC-induced toxic
effects we observed. We suggested that HA was an effective
protective agent that had antioxidant properties and could
decrease DNA damage and cell apoptosis induced by BAC.
In the future, a considerable improvement of ocular tolerance
may be obtained by adding HA to preserved ophthalmic drugs.
However, the experiments conducted in vitro may not reflect
the real situation in vivo. Therefore, further investigation is
still needed to confirm the significance of these findings in
vivo.
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